Source: Annual Congress 2006 - Pathophysiology of respiratory muscles
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. C. J. Langen, A. Haegens, M. C. J. M. Kelders, J. H. J. Vernooy, E. F. M. Wouters, A. M. W. J. Schols (Maastricht, Netherlands). Atrophy and increased expression of MuRF1 and atrogin in skeletal muscle following acute pulmonary inflammation. Eur Respir J 2006; 28: Suppl. 50, 3643

Member's Comments

No comment yet.

Related content which might interest you: Effects of inflammation on skeletal muscle Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=68 Year: 2003 Decreased expression of genes involved in skeletal muscle oxidative metabolism in COPD patients with muscle wasting Source: Annual Congress 2008 - Respiratory muscle pathophysiology Year: 2008 Skeletal muscle atrophy caused by acute pulmonary inflammation is dependent on a glycogen synthase kinase-3beta - glucocorticoid receptor signaling axis Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey Year: 2015 Hypoxia sensitizes skeletal muscle to fasting-induced muscle atrophy; role of AMPK activation Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015 Increased autophagy and reduced protein synthesis signaling are involved in pulmonary inflammation-induced skeletal muscle atrophy Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016 Acute pulmonary inflammation induces NF-κB- and ubiquitin 26S-proteasome-dependent diaphragm atrophy Source: Annual Congress 2010 - Interaction between respiratory and peripheral muscles Year: 2010 Hypoxia induces differential acute and chronic adaptations in regulation of skeletal muscle protein turnover Source: Annual Congress 2011 - Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation Year: 2011 Differential regulation of skeletal muscle myofilament protein expression in sepsis Source: International Congress 2017 – New insights into acute critical care Year: 2017 Atrophy and hypertrophy signalling in the diaphragm of patients with COPD Source: Eur Respir J 2010; 35: 549-556 Year: 2010 Skeletal muscle inflammatory markers in COPD patients with muscle wasting Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 Altered protein turnover signaling and myogenesis during impaired recovery of inflammation-induced muscle atrophy in emphysematous mice Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium Year: 2018 Uncoupling protein-3 content is decreased in peripheral skeletal muscle of patients with COPD Source: Eur Respir J 2003; 22: 88-93 Year: 2003 Hypoxia-induced muscle atrophy and impaired regulation of protein turnover are partially dependent on muscle glucocorticoid receptor signaling Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 In vitro and in vivo contractile properties of the vastus lateralis muscle in males with COPD Source: Eur Respir J 2003; 21: 273-278 Year: 2003 miR-424 and muscle wasting in pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 TNF-α-induced NF-κB activation stimulates skeletal muscle glycolytic metabolism through activation of HIF-1α Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Systemic inflammation is associated with mitophagy signalling in skeletal muscle of COPD patients Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 Differential effects of emphysema on skeletal muscle fibre atrophy in hamsters Source: Eur Respir J 2004; 23: 703-707 Year: 2004 Targeting NADPH oxidase-2 reduces cigarette smoke-induced lung inflammation and skeletal muscle wasting in mice Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018